MAPT and Alzheimer disease: In contrast to our findings, results in a paper on the longitudinal Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Ageing showed no association between a 21-SNP PRS and CSF p-tau levels in a small (n = 58) combined sample of cognitively normal and AD individuals [30].